SOURCE-LINKED INTELLIGENCE

ACCELERATING PLATFORMS FOR EVALUATING AND EXECUTING AI LIFECYCLES IN ADRD (APEX-ADRD) - PROJECT SUMMARY/ABSTRACT | OVERALL STRATEGY DESPITE THE 7M AMERICANS LIVING WITH ALZHEIMER’S DISEASE AND RELATED DEMENTIAS (ADRD) AT

USAspending · observation · Publication date unknown

ACCELERATING PLATFORMS FOR EVALUATING AND EXECUTING AI LIFECYCLES IN ADRD (APEX-ADRD) - PROJECT SUMMARY/ABSTRACT | OVERALL STRATEGY DESPITE THE 7M AMERICANS LIVING WITH ALZHEIMER’S DISEASE AND RELATED DEMENTIAS (ADRD) AT AN ANNUAL COST EXCEEDING $781B, AND NEARLY HALF OF DEMENTIA CASES BEING POTENTIALLY PREVENTABLE, ARTIFICIAL INTELLIGENCE (AI) HAS YET TO DELIVER ITS PROMISED TRANSFORMATION IN AGING AND ADRD CARE. FEW AI-BASED CLINICAL DECISION SUPPORT TOOLS FOR ADRD EXIST AND WERE TYPICALLY CLEARED THROUGH LOW-EVIDENCE PATHWAYS. MARKEDLY, CURRENT VALIDATION PRO- CESSES OFTEN REQUIRE YEARS, WH

Read original source ↗ Open in workspace

recordType

award

region

US

value

4899999

unit

USD